Rapid Micro Biosystems, Inc. (RPID)
1.20
-0.01
(-0.83%)
USD |
NASDAQ |
Sep 10, 16:00
1.20
0.00 (0.00%)
After-Hours: 20:00
Rapid Micro Biosystems Total Liabilities (Quarterly) : 40.70M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 40.70M |
| March 31, 2026 | 41.96M |
| December 31, 2025 | 41.65M |
| September 30, 2025 | 40.08M |
| June 30, 2025 | 21.04M |
| March 31, 2025 | 19.94M |
| December 31, 2024 | 22.82M |
| September 30, 2024 | 21.47M |
| June 30, 2024 | 22.50M |
| March 31, 2024 | 21.79M |
| December 31, 2023 | 25.46M |
| September 30, 2023 | 22.38M |
| Date | Value |
|---|---|
| June 30, 2023 | 21.32M |
| March 31, 2023 | 20.84M |
| December 31, 2022 | 26.48M |
| September 30, 2022 | 22.90M |
| June 30, 2022 | 21.18M |
| March 31, 2022 | 22.98M |
| December 31, 2021 | 20.19M |
| September 30, 2021 | 19.68M |
| June 30, 2021 | 57.93M |
| March 31, 2021 | 56.13M |
| December 31, 2020 | 45.18M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 6.604B |
| Bio-Rad Laboratories, Inc. | 3.078B |
| Bruker Corp. | 3.617B |
| Danaher Corp. | 39.78B |
| Harvard Bioscience, Inc. | 68.87M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 58.45M |
| Shareholders Equity (Quarterly) | 17.75M |
| Debt to Equity Ratio | 1.315 |
| Current Ratio | 2.521 |
| Net Debt Paydown Yield | -4.04% |